204 related articles for article (PubMed ID: 23797881)
1. Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakagawa N; Muto T; Sasaki H; Urabe K; Sueda T
J Gastrointest Surg; 2013 Aug; 17(8):1429-39. PubMed ID: 23797881
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
[TBL] [Abstract][Full Text] [Related]
3. Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma.
Urabe K; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Sasaki H; Hiyama E; Takahashi S; Sueda T
Dig Dis Sci; 2016 Mar; 61(3):774-84. PubMed ID: 26547754
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Prognostic Factors and the Efficacy of Adjuvant S-1 Chemotherapy in Patients with Post-surgery Extrahepatic Bile Duct Cancer.
Okabayashi T; Shima Y; Iwata J; Morita S; Sumiyoshi T; Sui K; Shimada Y; Iiyama T
Anticancer Res; 2017 Dec; 37(12):7049-7056. PubMed ID: 29187494
[TBL] [Abstract][Full Text] [Related]
5. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy with gemcitabine and S-1 after surgical resection for advanced biliary carcinoma: outcomes and prognostic factors.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Sakabe R; Kobayashi H; Kondo N; Nakagawa N; Sueda T
J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):306-13. PubMed ID: 22270151
[TBL] [Abstract][Full Text] [Related]
7. Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy.
Toyota K; Murakami Y; Kondo N; Uemura K; Nakagawa N; Takahashi S; Sueda T
Ann Surg Oncol; 2018 May; 25(5):1202-1210. PubMed ID: 29492748
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.
Kim HJ; Kim CY; Hur YH; Koh YS; Kim JC; Kim HJ; Cho CK
Surg Today; 2014 Oct; 44(10):1879-86. PubMed ID: 24535697
[TBL] [Abstract][Full Text] [Related]
9. Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma.
Shirai K; Ebata T; Oda K; Nishio H; Nagasaka T; Nimura Y; Nagino M
World J Surg; 2008 Nov; 32(11):2395-402. PubMed ID: 18795245
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutation is strongly associated with perineural invasion and represents an independent prognostic factor of intrahepatic cholangiocarcinoma after hepatectomy.
Chen TC; Jan YY; Yeh TS
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S675-81. PubMed ID: 22805857
[TBL] [Abstract][Full Text] [Related]
11. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.
Fisher SB; Patel SH; Kooby DA; Weber S; Bloomston M; Cho C; Hatzaras I; Schmidt C; Winslow E; Staley CA; Maithel SK
HPB (Oxford); 2012 Aug; 14(8):514-22. PubMed ID: 22762399
[TBL] [Abstract][Full Text] [Related]
12. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.
Dumitrascu T; Chirita D; Ionescu M; Popescu I
J Gastrointest Surg; 2013 May; 17(5):913-24. PubMed ID: 23319395
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
J Gastrointest Surg; 2009 Aug; 13(8):1470-9. PubMed ID: 19421824
[TBL] [Abstract][Full Text] [Related]
14. Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.
Scheuermann U; Kaths JM; Heise M; Pitton MB; Weinmann A; Hoppe-Lotichius M; Otto G
Eur J Surg Oncol; 2013 Jun; 39(6):593-600. PubMed ID: 23611755
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis of intrahepatic cholangiocarcinoma after resection.
Cho SY; Park SJ; Kim SH; Han SS; Kim YK; Lee KW; Lee SA; Hong EK; Lee WJ; Woo SM
Ann Surg Oncol; 2010 Jul; 17(7):1823-30. PubMed ID: 20165987
[TBL] [Abstract][Full Text] [Related]
16. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic invasion is an independent prognostic factor in pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapy with gemcitabine or S-1.
Aoyama T; Murakawa M; Katayama Y; Shiozawa M; Ueno M; Morimoto M; Yoshikawa T; Rino Y; Masuda M; Morinaga S
Hepatogastroenterology; 2015; 62(138):472-7. PubMed ID: 25916085
[TBL] [Abstract][Full Text] [Related]
18. Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma: A single-center study.
Choe JW; Kim HJ; Kim JS
Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):153-156. PubMed ID: 31974040
[TBL] [Abstract][Full Text] [Related]
19. [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy].
Kuga Y; Moriya T; Fukuda S; Nishida T
Gan To Kagaku Ryoho; 2016 Jun; 43(6):773-5. PubMed ID: 27306819
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
Wirasorn K; Ngamprasertchai T; Khuntikeo N; Pakkhem A; Ungarereevittaya P; Chindaprasirt J; Sookprasert A
J Gastroenterol Hepatol; 2013 Dec; 28(12):1885-91. PubMed ID: 23829232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
